Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 3/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.38 |
| ▸ | HPGD | P15428 | 3/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.38 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | CASP3 | P42574 | 1/20 | 0.38 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.38 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.38 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 7/20 | 0.35 |
| ▸ | LMNA | P02545 | 3/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.35 |
| ▸ | TP53 | P04637 | 1/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.35 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8211866 | 0.75 | HSP90AA1 (0.44) | CYP2C9CYP2D6MAPK1MAPTKMT2A | |
| SCHEMBL7084933 | 0.72 | MEN1 (0.51) | CYP1A2CYP2C19HPGDCYP2C9ALOX15 | |
| SCHEMBL23641843 | 0.66 | MAPT (0.46) | MAPTLMNAKMT2ACYP3A4MEN1 | |
| SCHEMBL10994448 | 0.66 | MAPT (0.49) | CYP1A2CYP2C19HPGDCYP2C9ALOX15 | |
| SCHEMBL396553 | 0.65 | HSD17B10 (0.59) | CYP1A2CYP2C19HPGDCYP2C9ALOX15 | |
| SCHEMBL28548520 | 0.65 | HSD17B10 (0.50) | CYP1A2CYP2C19HPGDCYP2C9ALOX15 | |
| SCHEMBL10998311 | 0.64 | HPGD (0.63) | CYP1A2CYP2C19HPGDCYP2C9ALOX15 | |
| SCHEMBL1254116 | 0.64 | KMT2A (0.64) | CYP1A2CYP2C19HPGDCYP2C9ALOX15 | |
| SCHEMBL4363059 | 0.64 | HPGD (0.58) | CYP1A2CYP2C19HPGDCYP2C9ALOX15 | |
| SCHEMBL7921362 | 0.64 | HSD17B10 (0.54) | CYP1A2CYP2C19HPGDCYP2C9ALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20030069312-A1 | Antidiabetic agents | LARDY CLAUDE (FR) | 2003-04-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030069312-A1 | Antidiabetic agents | SLC5A1, SLC5A2, GPR119 | CYP1A2 178/4885CYP2C19 976/4885HPGD 964/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.